Fran Horowitz
Chief Executive Officer at Abercrombie & Fitch Company
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Abercrombie & Fitch Company, 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 28, 2024 | ConAgra Brands Inc. | Grant or award | +5,857 | โ | โ |
| Apr 18, 2024 | Abercrombie & Fitch Company | Open-market sale | โ400,000 | $110.61 | $44,244,000 |
| Apr 1, 2024 | Abercrombie & Fitch Company | Grant or award | +214,758 | โ | โ |
| Apr 1, 2024 | Abercrombie & Fitch Company | Shares withheld for tax | โ96,321 | $131.84 | $12,698,961 |
| Mar 25, 2024 | Abercrombie & Fitch Company | Option exercise | +35,793 | โ | โ |
| Mar 25, 2024 | Abercrombie & Fitch Company | Shares withheld for tax | โ16,054 | $121.17 | $1,945,263 |
| Mar 22, 2024 | Abercrombie & Fitch Company | Option exercise | +40,017 | โ | โ |
| Mar 22, 2024 | Abercrombie & Fitch Company | Shares withheld for tax | โ17,948 | $134.97 | $2,422,442 |
| Mar 7, 2024 | Abercrombie & Fitch Company | Option exercise | +48,484 | โ | โ |
| Mar 7, 2024 | Abercrombie & Fitch Company | Shares withheld for tax | โ21,746 | $127.78 | $2,778,704 |
| Oct 13, 2023 | Abercrombie & Fitch Company | Option exercise | +67,568 | $22.46 | $1,517,577 |
| Oct 13, 2023 | Abercrombie & Fitch Company | Option exercise | +24,483 | $28.81 | $705,355 |
| Oct 13, 2023 | Abercrombie & Fitch Company | Shares withheld for tax | โ25,060 | $61.44 | $1,539,686 |
| Oct 13, 2023 | Abercrombie & Fitch Company | Sold back to the company | โ36,180 | $61.44 | $2,222,899 |
| Aug 28, 2023 | Abercrombie & Fitch Company | Option exercise | +25,048 | โ | โ |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.